Steroids used to desensitize penicillamine allergy in Wilson disease

Acta Paediatrica Taiwanica

Volumn 40, Issue 6, 1999, Pages 448-450

  Hsu, Hui Ling ^a   Huang, Fu Chen ^b   Ni, Yen Hsuan ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Desensitization; Penicillamine; Steroids; Wilson disease

Indexed keywords

PENICILLAMINE; PREDNISOLONE; STEROID;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DESENSITIZATION; DRUG HYPERSENSITIVITY; HEMOLYTIC ANEMIA; HUMAN; MALE; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; THROMBOCYTOPENIA; TREATMENT OUTCOME; WILSON DISEASE;

ADOLESCENT; DRUG HYPERSENSITIVITY; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PENICILLAMINE; PREDNISOLONE;

EID: 0033491315     PISSN: 00016578     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sternlieb I Perspectives on Wilson disease. Hepatology 1990, 12:1234-9.
2. Walshe JM. Penicillamine a new oral therapy for Wilson disease Am J Med 1956; 21 487-95
3. Thomas CG. Febrile penicillamine eruption. Arch Neurol 1972; 26:474.
4. Sternlieb I, Scheinberg IH Penicillamine therapy for hepatolenticular degeneration JAMA 1964, 189:748-54.
5. Pleskow RG, Grand RJ. Wilson disease In: Walker WA, ed Pediatric gastrointestinal disease. Mosby, 1996; 2: 1233-46
6. Scheinberg IH, Sternlieb I, Schlisky M, et al. Penicillamine may detoxify copper in Wilson disease Lancet 1987; 2: 95.
7. Collins JC, Scheinberg IH, Sternlieb I. Penicillamine prophylaxis for asymptomatic children with Wilson's disease Hepatology 1993; 18:128A (abstract).
8. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease Medicine (Baltimore) 1992; 71 139-64.
9. Walshe J M. Wilson disease Handbook of Clinical Neurology 1986, 49:223-8.
10. Burke JF, Flower RJ. Effect of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis Br Pharmacol 1979; 65:35-41.
11. Hammond CV, Hammond MD, Taylor WA Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung. Int Arch Allergy Appl Immunol 1982, 67 284-6
12. Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974; 53:240-6.
13. Holland CL, Malasky C, Bielory L. Rapid oral desensitization to isoniazid and rifampin. Chest 1990; 98.1518-9.
14. Stark BJ, Earl HS, Sullivan T. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin J Allergy Clin Immunol 1987; 79 523-32.
15. Toogood JH. Anaphylaxis in patients receiving beta-blocker drugs J Allergy Clin Immunol 1988, 81 1-5
16. Chan CY, Baker AL. Penicillamine hypersensitivity: Successful desensitization of patient with severe hepatic Wilson disease. Am J Gastroenterol 1994; 89:442-3
17. Walshe JM. Copper chelation in Wilson disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973, 42:441-52
18. Scheinberg H, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson disease. N Engl J Med 1987; 317:209-13.
19. Brewer GJ, Dick RD Treatment of Wilson disease with zinc XIII Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994; 123: 849-58.
20. Hill GM, Brewer GJ. Treatment of Wilson disease with zinc. I. oral zinc therapy regimens. Hepatology 1987, 7 522-8.
21. Brewer GJ, Dick RD, Johnson V, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994; 51:545-54
22. Walshe JM. Tetrathiomolybdate (MoS4) as an anti-copper agent in man In: Scheinberg IH, Walshe JM, eds. Orphan diseases and orphan drugs. Manchester: Manchester University Press, 1986, 76-85.